Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5B inhibitors. Assay should be used for patients with documented HCV genotype 1
Immediately following collection, thoroughly mix sample by gently inverting 5 times
Frozen
Polymerase chain reaction (PCR) amplification and DNA next generation sequencing
An interpretive report will be provided